Total Payments
$9,833
2024 Payments
$1,602
Companies
43
Transactions
768
Medicare Patients
1,869
Medicare Billing
$138,033
Payment Breakdown by Category
Food & Beverage$9,533 (97.0%)
Education$299.82 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,533 | 763 | 97.0% |
| Education | $299.82 | 5 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,333 | 329 | $0 (2024) |
| ABBVIE INC. | $1,746 | 102 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,040 | 69 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $795.50 | 49 | $0 (2024) |
| PFIZER INC. | $459.24 | 28 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $363.94 | 19 | $0 (2024) |
| UCB, Inc. | $277.92 | 15 | $0 (2020) |
| Braintree Laboratories, Inc. | $244.33 | 13 | $0 (2024) |
| Celgene Corporation | $193.59 | 13 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $191.31 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,602 | 85 | ABBVIE INC. ($243.55) |
| 2023 | $1,912 | 110 | Janssen Biotech, Inc. ($373.89) |
| 2022 | $1,673 | 99 | ABBVIE INC. ($544.70) |
| 2021 | $1,192 | 111 | Janssen Biotech, Inc. ($446.84) |
| 2020 | $433.23 | 45 | Janssen Biotech, Inc. ($214.90) |
| 2019 | $1,139 | 115 | Janssen Biotech, Inc. ($336.33) |
| 2018 | $1,132 | 112 | Janssen Biotech, Inc. ($268.54) |
| 2017 | $749.17 | 91 | Janssen Biotech, Inc. ($229.84) |
All Payment Transactions
768 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.35 | General |
| 12/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: Gastroenterology | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/07/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Gastroenterology | ||||||
| 10/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.44 | General |
| 09/28/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: Gastroenterology | ||||||
| 09/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Oncology | ||||||
| 09/10/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: GI | ||||||
| 08/27/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/22/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 486 | 515 | $75,026 | $39,896 |
| 2022 | 8 | 472 | 488 | $64,872 | $34,456 |
| 2021 | 12 | 512 | 554 | $59,441 | $36,401 |
| 2020 | 10 | 399 | 429 | $42,166 | $27,280 |
Total Patients
1,869
Total Services
1,986
Medicare Billing
$138,033
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 54 | 55 | $18,014 | $10,619 | 58.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 54 | 54 | $16,840 | $7,929 | 47.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 67 | 70 | $11,080 | $6,049 | 54.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 51 | $7,680 | $4,401 | 57.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 18 | 18 | $4,130 | $2,869 | 69.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $5,254 | $2,796 | 53.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 16 | 16 | $4,440 | $2,344 | 52.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $3,670 | $1,648 | 44.9% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 186 | 198 | $3,098 | $828.64 | 26.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2023 | 12 | 12 | $820.00 | $413.71 | 50.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 76 | 77 | $11,887 | $6,936 | 58.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 36 | 36 | $10,872 | $6,919 | 63.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 45 | 45 | $11,623 | $6,301 | 54.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 45 | $6,822 | $3,866 | 56.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 50 | 54 | $6,295 | $2,674 | 42.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 11 | 11 | $6,823 | $2,521 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $3,871 | $2,180 | 56.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $2,651 | $1,234 | 46.6% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2022 | 22 | 26 | $1,650 | $1,155 | 70.0% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 157 | 160 | $2,378 | $668.80 | 28.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 48 | 48 | $11,578 | $7,218 | 62.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 71 | 75 | $11,772 | $6,803 | 57.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 35 | 35 | $9,741 | $6,803 | 69.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 64 | 76 | $7,180 | $4,759 | 66.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 16 | 16 | $3,641 | $2,596 | 71.3% |
About Dr. George Kunze, M.D
Dr. George Kunze, M.D is a Gastroenterology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659356541.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Kunze, M.D has received a total of $9,833 in payments from pharmaceutical and medical device companies, with $1,602 received in 2024. These payments were reported across 768 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($9,533).
As a Medicare-enrolled provider, Kunze has provided services to 1,869 Medicare beneficiaries, totaling 1,986 services with total Medicare billing of $138,033. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Rochester, NY
- Active Since 12/13/2005
- Last Updated 12/08/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1659356541
Products in Payments
- STELARA (Biological) $2,128
- XIFAXAN (Drug) $728.23
- ENTYVIO (Biological) $499.50
- RINVOQ (Biological) $448.31
- XELJANZ (Drug) $447.17
- SKYRIZI (Biological) $341.95
- Linzess (Drug) $282.72
- Cimzia (Drug) $277.92
- DUPIXENT (Biological) $229.61
- TRULANCE (Drug) $210.43
- ZEPOSIA (Drug) $193.59
- VOQUEZNA (Drug) $191.31
- HUMIRA (Biological) $189.82
- LINZESS (Drug) $189.75
- Creon (Drug) $165.90
- IBSRELA (Drug) $152.77
- OCALIVA (Drug) $151.10
- MAVYRET (Drug) $142.85
- SUTAB (Drug) $141.10
- TREMFYA (Drug) $120.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Rochester
Edward Loftus, M.d, M.D
Gastroenterology — Payments: $379,661
Gastroenterology $379,661
Christopher Gostout, M.d, M.D
Gastroenterology — Payments: $317,848
Gastroenterology $317,848
Vivek Kaul, Md, MD
Gastroenterology — Payments: $307,068
Gastroenterology $307,068
Todd Baron, M.d, M.D
Gastroenterology — Payments: $296,029
Gastroenterology $296,029
Russell Wiesner, M.d, M.D
Gastroenterology — Payments: $231,350
Gastroenterology $231,350
Joseph Murray, M.d, M.D
Gastroenterology — Payments: $200,483
Gastroenterology $200,483